The safety and efficacy of FOLFOXIRI plus molecular target therapy as a first-line treatment for metastatic colorectal cancer: A multicentre retrospective study

A Retrospective Study of the Safety and Efficacy of a First-Line Treatment with Modified FOLFOX-4 in Unresectable Advanced or Recurrent Gastric Cancer Patients

Chemotherapy ◽

10.1159/000345742 ◽

2012 ◽

Vol 58 (5) ◽

pp. 411-418 ◽

Cited By ~ 8

Author(s):

Yung-Sung Yeh ◽

Hsiang-Lin Tsai ◽

Cheng-Jen Ma ◽

Deng-Chyang Wu ◽

Chien-Yu Lu ◽

...

Keyword(s):

Gastric Cancer ◽

Retrospective Study ◽

Cancer Patients ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

Recurrent Gastric Cancer ◽

Gastric Cancer Patients ◽

Safety and efficacy of FOLFOXIRI with or without targeted agents as first-line treatment of selected elderly metastatic colorectal cancer patients: a pooled analysis of GONO studies

Annals of Oncology ◽

10.1093/annonc/mdw335.14 ◽

2016 ◽

Vol 27 ◽

pp. iv43

Author(s):

D. Rossini ◽

M. Casagrande ◽

R. Moretto ◽

F. Loupakis ◽

C. Cremolini ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Pooled Analysis ◽

Line Treatment ◽

Targeted Agents ◽

First Line ◽

Safety And Efficacy ◽

Colorectal Cancer Patients ◽

438P First line treatment patterns in BRAFV600E-mutant metastatic colorectal cancer patients (mCRC): The CAPSTAN European retrospective study

Annals of Oncology ◽

10.1016/j.annonc.2021.08.959 ◽

2021 ◽

Vol 32 ◽

pp. S553

Author(s):

B. Asselain ◽

E. Martinelli ◽

C. Cremolini ◽

T. Mazard ◽

J. Vidal ◽

...

Keyword(s):

Colorectal Cancer ◽

Retrospective Study ◽

Cancer Patients ◽

Treatment Patterns ◽

Line Treatment ◽

First Line ◽

Colorectal Cancer Patients ◽

Safety and efficacy of bevacizumab (Bev) when added to oxaliplatin/fluoropyrimidine (O/F) regimens as first-line treatment of metastatic colorectal cancer (mCRC): TREE 1 & 2 Studies

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3515 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3515-3515 ◽

Cited By ~ 26

Author(s):

H. S. Hochster ◽

L. Welles ◽

L. Hart ◽

R. K. Ramanathan ◽

J. Hainsworth ◽

...

Keyword(s):

Colorectal Cancer ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

P-35 HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of first-line treatment

Annals of Oncology ◽

10.1016/j.annonc.2021.05.090 ◽

2021 ◽

Vol 32 ◽

pp. S108

Author(s):

K. Ito ◽

S. Yuki ◽

S. Nakano ◽

M. Yagisawa ◽

K. Sawada ◽

...

Keyword(s):

Colorectal Cancer ◽

Cohort Study ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

104P Safety and efficacy of HLX04 versus reference bevacizumab in combination with XELOX or mFOLFOX6 as first-line treatment for metastatic colorectal cancer: A randomised, double-blind phase III study

Annals of Oncology ◽

10.1016/j.annonc.2020.10.124 ◽

2020 ◽

Vol 31 ◽

pp. S1282

Author(s):

S. Qin ◽

J. Li ◽

Y. Bai ◽

Y. Shu ◽

W. Li ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Double Blind ◽

Safety And Efficacy ◽

Phase Iii Study ◽

Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study

British Journal of Cancer ◽

10.1038/bjc.2017.413 ◽

2017 ◽

Vol 118 (3) ◽

pp. 325-330 ◽

Cited By ~ 8

Author(s):

Maëva Salimon ◽

Caroline Prieux-Klotz ◽

David Tougeron ◽

Vincent Hautefeuille ◽

Morgane Caulet ◽

...

Keyword(s):

Retrospective Study ◽

Line Treatment ◽

First Line ◽

Platinum Based Chemotherapy ◽

Multicentre Retrospective Study ◽

A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6605938 ◽

2010 ◽

Vol 103 (10) ◽

pp. 1536-1541 ◽

Cited By ~ 8

Author(s):

R López ◽

M Salgado ◽

M Reboredo ◽

C Grande ◽

J C Méndez ◽

...

Keyword(s):

Colorectal Cancer ◽

Observational Study ◽

Retrospective Observational Study ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal cancer (MCRC): Results of the safety and efficacy analysis

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3507 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3507-3507 ◽

Cited By ~ 14

Author(s):

H.-T. Arkenau ◽

H. Schmoll ◽

S. Kubicka ◽

A. Kretzschmar ◽

W. Freier ◽

...

Keyword(s):

Colorectal Cancer ◽

Folinic Acid ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

Efficacy Analysis ◽

PD-009 Safety and efficacy of FOLFOXIRI with or without targeted agents as first-line treatment of selected elderly metastatic colorectal cancer patients: a pooled analysis of GONO studies

Annals of Oncology ◽

10.1093/annonc/mdw200.09 ◽

2016 ◽

Vol 27 ◽

pp. ii104

Author(s):

M. Casagrande ◽

R. Moretto ◽

F. Loupakis ◽

C. Cremolini ◽

G. Masi ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Pooled Analysis ◽

Line Treatment ◽

Targeted Agents ◽

First Line ◽

Safety And Efficacy ◽

Colorectal Cancer Patients ◽